Literature DB >> 35237979

Use of Rabbit Models to Study Atherosclerosis.

Jianglin Fan1,2, Manabu Niimi3, Yajie Chen3,4, Ritsuko Suzuki5, Enqi Liu6.   

Abstract

Rabbits are a useful animal model for examining human hyperlipidemia and atherosclerosis because they have unique features of lipoprotein metabolism that are similar to those in humans. Feeding rabbits a cholesterol-rich diet is a simple means to induce experimental atherosclerosis. Indeed, cholesterol-fed rabbits were first applied to address the relationship between dietary cholesterol and atherosclerosis more than 100 years ago. However, the methods for investigating atherosclerosis using cholesterol-fed rabbits have not been well formulated. In this chapter, we attempt to provide readers with the essential methods to use cholesterol-fed rabbits in the examination of atherosclerosis from cholesterol diet preparation to lesion analysis. These protocols are compiled for both experienced and young researchers who intend to use rabbits for the investigation of lipoprotein metabolism and atherosclerosis.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Animal models; Atherosclerosis; Hypercholesterolemia; Plaques; Rabbits

Mesh:

Substances:

Year:  2022        PMID: 35237979     DOI: 10.1007/978-1-0716-1924-7_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Macrophage metalloelastase accelerates the progression of atherosclerosis in transgenic rabbits.

Authors:  Jingyan Liang; Enqi Liu; Ying Yu; Shuji Kitajima; Tomonari Koike; Yingji Jin; Masatoshi Morimoto; Kinta Hatakeyama; Yujiro Asada; Teruo Watanabe; Yasuyuki Sasaguri; Shigeyuki Watanabe; Jianglin Fan
Journal:  Circulation       Date:  2006-04-25       Impact factor: 29.690

2.  Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part I.

Authors:  Daniel Steinberg
Journal:  J Lipid Res       Date:  2004-04-21       Impact factor: 5.922

3.  Angiotensin II Destabilizes Coronary Plaques in Watanabe Heritable Hyperlipidemic Rabbits.

Authors:  Shen Li; Yan-Ning Wang; Manabu Niimi; Bo Ning; Yajie Chen; Dedong Kang; Ziyun Wang; Qi Yu; Ahmed Bilal Waqar; Enqi Liu; Jifeng Zhang; Masashi Shiomi; Y Eugene Chen; Jianglin Fan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-17       Impact factor: 8.311

4.  Dietary cholesterol atherogenic changes in juvenile rabbits.

Authors:  Yuka Keyamura; Chifumi Nagano; Masayuki Kohashi; Manabu Niimi; Masanori Nozako; Takashi Koyama; Hiroyuki Itabe; Tomohiro Yoshikawa
Journal:  Biol Pharm Bull       Date:  2015       Impact factor: 2.233

Review 5.  Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine.

Authors:  Jianglin Fan; Shuji Kitajima; Teruo Watanabe; Jie Xu; Jifeng Zhang; Enqi Liu; Y Eugene Chen
Journal:  Pharmacol Ther       Date:  2014-09-30       Impact factor: 12.310

6.  Increased Hepatic Expression of Endothelial Lipase Inhibits Cholesterol Diet-Induced Hypercholesterolemia and Atherosclerosis in Transgenic Rabbits.

Authors:  Chuan Wang; Kazutoshi Nishijima; Shuji Kitajima; Manabu Niimi; Haizhao Yan; Yajie Chen; Bo Ning; Fumikazu Matsuhisa; Enqi Liu; Jifeng Zhang; Y Eugene Chen; Jianglin Fan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-05-25       Impact factor: 8.311

Review 7.  Principles and Applications of Rabbit Models for Atherosclerosis Research.

Authors:  Jianglin Fan; Yajie Chen; Haizhao Yan; Manabu Niimi; Yanli Wang; Jingyan Liang
Journal:  J Atheroscler Thromb       Date:  2017-10-19       Impact factor: 4.928

8.  Macrophage-derived MMP-9 enhances the progression of atherosclerotic lesions and vascular calcification in transgenic rabbits.

Authors:  Yajie Chen; Ahmed Bilal Waqar; Kazutoshi Nishijima; Bo Ning; Shuji Kitajima; Fumikazu Matsuhisa; Lu Chen; Enqi Liu; Tomonari Koike; Ying Yu; Jifeng Zhang; Yuqing Eugene Chen; Huijun Sun; Jingyan Liang; Jianglin Fan
Journal:  J Cell Mol Med       Date:  2020-03-03       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.